Neurocrine Biosciences, Inc. (BVMF:N1BI34)
Brazil · Delayed Price · Currency is BRL 34.08
0.00 (0.00%)
At close: Feb 5, 2026
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of 73.48 billion as of February 6, 2026. Its market cap has decreased by -16.91% in one year.
Market Cap
73.48B
Enterprise Value
70.17B
Revenue
14.30B
Ranking
n/a
PE Ratio
32.22
Stock Price
34.08
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 206.46M to 73.48B, an increase of 35,491.90%. That is a compound annual growth rate of 21.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 73.48B | -5.66% |
| Dec 31, 2025 | 77.89B | -8.88% |
| Dec 31, 2024 | 85.48B | 36.07% |
| Dec 29, 2023 | 62.82B | 3.48% |
| Dec 30, 2022 | 60.70B | 34.84% |
| Dec 31, 2021 | 45.02B | -3.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 91.65B |
| Raia Drogasil | 46.56B |
| Hypera | 14.97B |
| Fleury | 9.23B |
| Odontoprev | 6.46B |
| Diagnósticos da América | 5.27B |
| Empreendimentos Pague Menos | 4.17B |
| Oncoclínicas do Brasil Serviços Médicos | 2.77B |